Sales y derivados de API
Las sales de los Ingredientes Farmacéuticos Activos (API) son compuestos formados por la reacción de un ácido con una base, resultando en un equilibrio iónico. Estas sales suelen mejorar la solubilidad y estabilidad de los APIs, facilitando su absorción en el cuerpo. Los derivados de API son variantes químicas de un principio activo que pueden tener propiedades mejoradas o modificadas para optimizar su eficacia terapéutica. Las sales de APIs se utilizan en la formulación de medicamentos orales, inyectables y tópicos. Además, los derivados de APIs pueden mejorar la farmacocinética de los fármacos, como la liberación controlada de activos.
En CymitQuimica contamos con sales y derivados de APIs con la pureza y calidad necesarias para investigación y desarrollo de formulaciones farmacéuticas.
Se han encontrado 79404 productos de "Sales y derivados de API"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Decitabine Related Compound F (1-(2-Deoxy-D-ribofuranosyl)-3-guanylurea)
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFórmula:C7H14N4O4Forma y color:White Crystalline PowderPeso molecular:218.1015Repaglinide Related Compound C ((S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl] benzoic acid)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C30H34N2O4Forma y color:White PowderPeso molecular:486.25186Orlistat Related Compound C (Triphenylphosphine Oxide)
CAS:Non-halogenated organo-phosphorous derivatives, nesoiFórmula:C18H15OPForma y color:White Beige PowderPeso molecular:278.08605Pergolide Sulfoxide ((8β)-8-[(Methylsulfinyl)methyl]-6-propyl-D-ergoline)
CAS:Alkaloids of rye ergot and their derivatives; salts thereof, nesoiFórmula:C19H26N2OSForma y color:PowderPeso molecular:330.17658Rivaroxaban phthalimido ethyl ester analog ((S)-1-(1,3-dioxoisoindolin-2-yl)-3-((ethoxycarbonyl)(4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C29H26ClN3O8SForma y color:White Off-White SolidPeso molecular:611.11291Urea Related Compound A (Dicarbonimidic diamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFórmula:C2H5N3O2Forma y color:White PowderPeso molecular:103.03818Methyl 12-Hydroxystearate
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFórmula:C19H38O3Forma y color:White Off-White PowderPeso molecular:314.2821Methotrexate Related Compound E (4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C15H15N7O2·5HClForma y color:Yellow Tan Orange SolidPeso molecular:325.12872Epinastine Related Compound A ((6,11-Dihydro-5H-dibenzo[b,e]azepin-6-yl)methanamine fumarate)
CAS:AntihistaminesFórmula:C15H16N2·C4H4O4Forma y color:Off-White Brown Crystalline PowderPeso molecular:340.14231Triamcinolone Acetonide Related Compound B (9-Fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-(11β,16α)-pregna-1,4,14-triene-3,20-dione)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatives of ketoneFórmula:C24H29FO6Forma y color:PowderPeso molecular:432.19482Norfloxacin Related Compound K (6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C15H16FN3O3Forma y color:Off-White SolidPeso molecular:305.11757Torsemide Related Compound E (4-(3-Tolyl)-2H-pyrido[4,3-e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C13H11N3O3SForma y color:White PowderPeso molecular:289.05211Diclofenac Sodium
CAS:Aromatic amino-acids and their esters,other than thoseFórmula:C14H11Cl2NO2·NaForma y color:PowderPeso molecular:318.00645Voriconazole Related Compound D ((2RS,3SR)-2-(2,4-difluorophenyl)-3-(pyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C16H15F2N5OForma y color:White Off-White SolidPeso molecular:331.12447Valsartan Related Compound A (N-Valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}D-valine)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C24H29N5O3Forma y color:Off-White PowderPeso molecular:435.22704Azathioprine Related Compound A (1-Methyl-4-nitro-1H-imidazol-5-amine)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C4H6N4O2Forma y color:Yellow PowderPeso molecular:142.04908Haloperidol Related Compound B (4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(2-fluorophenyl)butan-1-one)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C21H23ClFNO2Forma y color:White Off-White PowderPeso molecular:375.14013Theophylline Related Compound F (7-(2-Hydroxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione)
CAS:Theophylline and aminophylline (excluding fenetylline) and their derivatives, salts thereof, not elsewhere specified or includedFórmula:C9H12N4O3Forma y color:White PowderPeso molecular:224.090943-O-Methylmethyldopa
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C11H15NO4·H2OForma y color:White PowderPeso molecular:225.10011Tinidazole Related Compound B (1-(2-ethyl-sulfonylethyl)-2-methyl-4-nitroimidazole)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFórmula:C8H13N3O4SForma y color:Off-White Cream PowderPeso molecular:247.06268Amlodipine Related Compound D (3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1,3-dioxoisoindolin-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C28H27ClN2O7Forma y color:Off-White PowderPeso molecular:538.15068Azacitidine Related Compound A (4-Amino-1,3,5-triazin-2(1H)-one)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFórmula:C3H4N4OForma y color:White Off-White PowderPeso molecular:112.03851Quetiapine Related Compound G (Dibenzo[b,f][1,4]thiazepin-11(10H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C13H9NOSForma y color:White Off-White PowderPeso molecular:227.04049Ecamsule Related Compound D (((1SR,4RS)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatFórmula:C10H16O4SForma y color:White Beige PowderPeso molecular:232.07693Glycopyrrolate Erythro Isomer ((RS)-3-[(RS)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidinium bromide)
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C19H28BrNO3Forma y color:White PowderPeso molecular:398.33Ticagrelor Related Compound B
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C23H28F2N6O4SForma y color:White Off-White Crystalline PowderPeso molecular:522.18608Deferasirox System Suitability Mixture (A mixture containing Deferasirox, Benzoxazinone analog, Deferasirox ethyl ester, Deferasirox 1,2-isomer, Deferasirox 1,3-isomer and Salicylimide)
Aromatic or modified aromatic heterocyclic compounds withnitrogen heteroForma y color:White PowderAtenolol Related Compound D (2-[4-(3-Chloro-2-hydroxypropoxy)phenyl]acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C11H14ClNO3Forma y color:White SolidPeso molecular:243.06622Sibutramine Related Compound B (N-{1-[1-(3-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride)
Aromatic monoamines not elsewhere specified or includedFórmula:C17H26ClN·HClForma y color:White PowderPeso molecular:316.31Almotriptan Related Compound A ({3-[2-(Dimethylamino)ethyl]-5-[(pyrrolidine-1-yl)sulfonylmethyl]-1H-indol-1-yl}methanol)
CAS:Sulfonamides, nesoiFórmula:C18H27N3O3SForma y color:White Crystalline PowderPeso molecular:365.17731Maprotiline Related Compound D (3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2-en-1-amine, hydrochloride)
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFórmula:C20H21N·HClForma y color:White PowderPeso molecular:275.1674Adapalene Related Compound B (Methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFórmula:C29H30O3Forma y color:PowderPeso molecular:426.21949Meloxicam Related Compound C (Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C13H15NO5SForma y color:White Light Pink Solid PowderPeso molecular:297.06709Dalfampridine Related Compound C (1,3-Di(pyridin-4-yl)urea)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C11H10N4OForma y color:White SolidPeso molecular:214.08546Amlodipine Related Compound C (Dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H18ClNO4Forma y color:Off-White Yellow Crystalline PowderPeso molecular:335.09244Rivaroxaban Related Compound J
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C38H36Cl2N6O10S2Forma y color:Off-White PowderPeso molecular:870.13114Fluvastatin Related Compound B ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1, dimethylethyl ester)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C28H34FNO4Forma y color:PowderPeso molecular:467.24719Estriol Related Compound A (Estra-1,3,5(10),9(11)-tetraene-3,16α,17β-triol)
CAS:Estrogens and progestinsFórmula:C18H22O3Forma y color:Cream Off-White PowderPeso molecular:286.15689Molindone Related Compound A (3-Ethyl-2-methyl-1,5,6,7-tetrahydro-4H-indol-4-one)
CAS:Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFórmula:C11H15NOForma y color:Off-White PowderPeso molecular:177.11536Betamethasone Dipropionate Related Compound B (9-Fluoro-11β,21-dihydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-17-yl propionate)
CAS:Halogenated derivatives of adrenal cortical hormonesFórmula:C25H33FO6Forma y color:White PowderPeso molecular:448.22612Nateglinide Related Compound A (trans-4-isopropylcyclohexanecarboxylic acid)
CAS:Cyclanic, cyclenic or cycloterpenic monocarboxylic acidFórmula:C10H18O2Forma y color:White CrystalsPeso molecular:170.13068Clopidogrel Related Compound A ((+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H14ClNO2S·HClForma y color:Off-White PowderPeso molecular:307.04338Dimenhydrinate Related Compound E (8-chloro-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C8H9ClN4O2Forma y color:White Off-White PowderPeso molecular:228.0414Irinotecan Related Compound D ((R)-9-[(1,4'-Bipiperidine)-1'-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline hydrochloride, trihydrate)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:C33H38N4O6·HCl·3H2OForma y color:White Light Yellow PowderPeso molecular:677.19Paliperidone Related Compound A (3-Ethyl-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-α]pyrimidin-4-one)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C11H16N2O2Forma y color:Off-White PowderPeso molecular:208.12118Ziprasidone Related Compound B (5-{2-[4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloroindoline-2,3-dione)
CAS:Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFórmula:C21H19ClN4O2SForma y color:Dark Yellow PowderPeso molecular:426.09172Phenylbutyrate Related Compound C (4-cyclohexylbutanoic acid)
CAS:Cyclanic, cyclenic or cycloterpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivativesFórmula:C10H18O2Forma y color:White PowderPeso molecular:170.13068Exemestane Related Compound A (6-Methyleneandrosta-4-ene-3,17-dione)
CAS:Cyclanic, cyclenic or cycloterpenic ketones without othFórmula:C20H26O2Forma y color:PowderPeso molecular:240.0Iopromide Related Compound B (5-(Acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C17H22I3N3O7Forma y color:White Off-White PowderPeso molecular:760.85919Ethyl 4-nitrobenzoate
CAS:Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFórmula:C9H9NO4Forma y color:Light Yellow PowderPeso molecular:195.05316Meloxicam Related Compound B (5-Methylthiazol-2-amine)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C4H6N2SForma y color:Light Yellow Light Brown Crystalline PowderPeso molecular:114.02517Dexketoprofen Tromethamine
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C16H14O3·C4H11NO3Forma y color:White PowderPeso molecular:375.16819Tacrolimus 8-epimer
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C44H69NO12Forma y color:White PowderPeso molecular:803.48198Bosentan Related Compound E (4-(tert-butyl)benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C10H15NO2SForma y color:PowderPeso molecular:213.08235Ceftriaxone Sodium E-Isomer
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H16N8Na2O7S3Forma y color:Off-White PowderPeso molecular:598.00995Trazodone Related Compound C (2-{3-[4-(4-Chlorophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C19H22ClN5O·HClForma y color:Off-White PowderPeso molecular:371.15129Ethylparaben
CAS:Carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides etc, nesoiFórmula:C9H10O3Forma y color:White Colorless SolidPeso molecular:166.17Verapamil Related Compound E (3,4-dimethoxybenzaldehyde)
CAS:Aldehyde-ethers, aldehyde-phenols and aldehydes with otFórmula:C9H10O3Forma y color:PowderPeso molecular:166.06299Prednicarbate Related Compound A (1,2-Dihydroprednicarbate)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C27H38O8Forma y color:White PowderPeso molecular:490.25667Trazodone Related Compound F (1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C13H18Cl2N2·ClHForma y color:White PowderPeso molecular:308.06138Clonazepam Related Compound A (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril)
CAS:Lactams not elsewhere specified or includedFórmula:C15H10ClN3O3Forma y color:Yellow-Orange PowderPeso molecular:315.04107Ulipristal Acetate Related Compound A (11β-[4-(Dimethylamino)phenyl]-5α-hydroxy-20-oxospiro{19-norpregna-9-en-3,2'-[1,3]dioxolan}-17-yl acetate)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C32H43NO6Forma y color:Light Grey Blue PowderPeso molecular:537.30904Iopamidol Related Compound C (4-chloro-N1, N3-bis(1,3-dihydroxypropan-2-yl)-5-(S)-lactamido-2,6-diiodoisophthalamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C17H22ClI2N3O8Forma y color:White PowderPeso molecular:684.91849Cevimeline trans-Isomer ((2RS,2'SR)-2'-Methyl-4-azaspiro{bicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane} hydrochloride hemihydrate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C10H17NOS·HClH2OForma y color:White PowderPeso molecular:244.78Isoguaifenesin
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFórmula:C10H14O4Forma y color:Off-White PowderPeso molecular:198.08921Diethyltoluamide Related Compound A (N,N-Diethyl-4-toluamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C12H17NOForma y color:White CrystalsPeso molecular:191.131015-Methylisoxazole-4-carboxylic Acid (5-Methyl-1,2-oxazole-4-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C5H5NO3Forma y color:White SolidPeso molecular:127.02694Prostaglandin B1 ((13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic acid)
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFórmula:C20H32O4Forma y color:White Off-White SolidPeso molecular:336.23006Fluphenazine Related Compound B (10-{3-[4-(2-Hydroxyethyl)piperazin-1-yl]propyl}-2-(trifluoromethyl)-10H-phenothiazine 5,5-dioxide)
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFórmula:C22H26F3N3O3SForma y color:Off-White SolidPeso molecular:469.1647Atovaquone Related Compound A (cis-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone)
CAS:Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFórmula:C22H19ClO3Forma y color:Yellow Crystalline PowderPeso molecular:366.84Roflumilast Related Compound B (N-(3,5-Dichloropyridin-4-yl)-4-(difluoromethoxy)-3-hydroxybenzamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C13H8Cl2F2N2O3Forma y color:White PowderPeso molecular:347.988Pitavastatin Related Compound B ((4R,6S)-6-{(E)-2-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]vinyl}-4-hydroxytetrahydro-2H-pyran-2-one)
CAS:Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFórmula:C25H22FNO3Forma y color:Off-White PowderPeso molecular:403.15837Doxepin Related Compound B ((11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C19H23NO2Forma y color:White Off-White PowderPeso molecular:297.17288Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C14H10ClNOForma y color:Light Yellow PowderPeso molecular:243.04509Triamterene Related Compound B (2,7-diamino-4-hydroxy-6-phenylpteridine)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C12H10N6OForma y color:Light Yellow Crystalline PowderPeso molecular:254.09161Abacavir Related Compound B ([4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol)
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C10H14ON4ClForma y color:Cream PowderPeso molecular:241.08561Methimazole Related Compound C (1-Methyl-2-(methylthio)-1H-imidazole)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C5H8N2SForma y color:Clear Pale Yellow LiquidPeso molecular:128.04082Ziprasidone Related Compound F (Sodium 2-(2-amino-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-4-chlorophenyl)acetate monohydrate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C21H22ClN4NaO2S·H2OForma y color:White Off-White SolidPeso molecular:470.11553Dexmedetomidine Related Compound C (5-[1-(2,3-Dimethylphenyl)ethyl]-1-ethyl-1H-imidazole)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C15H20N2Forma y color:White SolidPeso molecular:228.16265Phenylbutyrate Related Compound A (4-oxo-4-phenylbutanoic acid)
CAS:Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFórmula:C10H10O3Forma y color:PowderPeso molecular:178.06299Nateglinide Related Compound C (N-(cis-4-isopropylcyclohexanecarbonyl)-D-phenylalanine)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C19H27NO3Forma y color:White PowderPeso molecular:317.19909Zolmitriptan Related Compound B ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H23N3OForma y color:White SolidPeso molecular:261.18411Celecoxib Related Compound D ((E)-4-{2-[1-(p-Tolyl)ethylidene]hydrazineyl}benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C15H17N3O2SForma y color:Pale Yellow Off-White SolidPeso molecular:303.10415Buspirone Related Compound L (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione)
CAS:Imides and their derivatives (excluding sacharin), salt thereofFórmula:C13H20ClNO2Forma y color:Colorless Clear Light Yellow LiquidPeso molecular:257.11826D-Valganciclovir (2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-methoxy]-3-hydroxypropyl D-valine ester monohydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C14H22N6O5·HCIForma y color:Off-White PowderPeso molecular:494.07746Valacyclovir Related Compound E (2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-benzyloxycarbonyl-L-valinate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C21H26N6O6Forma y color:White Crystalline PowderPeso molecular:458.19138Diltiazem Related Compound A (AS) (trans-diltiazem hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C22H26N2O4SForma y color:PowderPeso molecular:450.98Azathioprine Related Compound G (6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purin-2-amine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C9H8N8O2SForma y color:PowderPeso molecular:292.04909Rivaroxaban N-methylphthalamido Analog ((S)-N1-methyl-N2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C23H24N4O6Forma y color:White Off-White SolidPeso molecular:452.169583-Amino-2,4,6-triiodobenzoic Acid
CAS:Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, not elsewhere specified or includedFórmula:C7H4I3NO2Forma y color:Light Yellow Amorphous PowderPeso molecular:514.73762Antazoline Related Compound A (N-(2-Aminoethyl)-2-[benzyl(phenyl)amino]acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C17H21N3OForma y color:SolidPeso molecular:283.16846Verapamil Related Compound A (3,4-Dimethoxy-α-[3-(methylamino)propyl]-α-(1-methylethyl)-benzeneacetonitrile monohydrochloride)
CAS:Nitrile function compounds, not elsewhere specified orFórmula:C17H26N2O2·HClForma y color:White PowderPeso molecular:290.19943Lufenuron Related Compound C (N-[3-Chloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylcarbamoyl]-2,6-difluorobenzamide)
CAS:Ureines and their derivatives; salts thereofFórmula:C17H9ClF8N2O3Forma y color:SolidPeso molecular:476.0174Ciclopirox Related Compound B (6-Cyclohexyl-4-methyl-2-pyrone)
CAS:Lactones nesoiFórmula:C12H16O2Forma y color:Yellow White Crystalline PowderPeso molecular:192.26Olanzapine Related Compound B (2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C12H10N2OSForma y color:Pale Yellow Dark Yellow PowderPeso molecular:230.05138Entecavir Related Compound A (9-[(1S,3R,4S)-4-Dimethylphenylsilyl-3-(benzyloxymethyl)-2-methylenecyclopentyl]guanine)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C27H31N5O2SiForma y color:White Light Yellow PowderPeso molecular:485.2247Dofetilide Related Compound B (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide)
CAS:Sulfonamides, nesoiFórmula:C19H27N3O6S2Forma y color:Off-White PowderPeso molecular:457.13413Tetrahydrozoline Related Compound A (1,2,3,4-Tetrahydronaphthalene-1-carbonitrile)
CAS:Nitrile function compounds, nesoiFórmula:C11H11NForma y color:Colorless Light Yellow Yellow Green LiquidPeso molecular:157.08915Nicotine Related Compound D (3-(4,5-dihydro-3H-pyrrol-2-yl)pyridine fumarate)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:C9H10N2Forma y color:White Light Brown PowderPeso molecular:146.0844Risperidone Related Compound G (3-{2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C23H28FN3O3Forma y color:Off-White PowderPeso molecular:413.21147Clonazepam Related Compound B (2-Amino-2'-chloro-5-nitrobenzophenone)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFórmula:C13H9ClN2O3Forma y color:Yellow PowderPeso molecular:276.03017Sulfasalazine Related Compound K (5-{4-[N-(6-Methylpyridin-2-yl)sulfamoyl]phenyldiazenyl}salicylic acid)
CAS:Sulfonamides, nesoiFórmula:C19H16N4O5SForma y color:Yellow PowderPeso molecular:412.08414Sulindac Related Compound C ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylthio)benzylidene]-1H-inden-3-yl}acetic acid)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Fórmula:C20H17FO2SForma y color:Yellow PowderPeso molecular:340.09333Temazepam Related Compound F (7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione)
CAS:Heterocyclic compounds (excluding aromatic or modifiedFórmula:C16H13ClN2O2Forma y color:White Crystalline PowderPeso molecular:300.06656Uridine (1-β-D-Ribofuranosylpyrimidine-2,4(1H,3H)-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C9H12N2O6Forma y color:PowderPeso molecular:244.069542,3-Dimethylaniline
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFórmula:C8H11NForma y color:Clear Yellow Amber Red Brown LiquidPeso molecular:121.08915Letrozole Related Compound A (4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C17H11N5Forma y color:White Off-White PowderPeso molecular:285.10145Orphenadrine Related Compound E (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C18H23NOForma y color:Light Yellow LiquidPeso molecular:269.17796Amoxicillin Related Compound B (L-amoxicillin)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H19O5N3SForma y color:PowderPeso molecular:365.10454Ecamsule Related Compound C (terephthalic acid)
CAS:Terephthalic acid and its saltsFórmula:C8H6O4Forma y color:White Off-White SolidPeso molecular:166.13Methylisoindolinedione (2-methylisoindoline-1,3-dione)
CAS:Imides and their derivatives (excluding sacharin), and salts thereofFórmula:C9H7NO2Forma y color:White Off-White SolidPeso molecular:161.04768Particle Count Set (2 blanks (28 mL each) and 2 suspensions (25 mL each))
Polystyrene,nesoiForma y color:Clear Milky Liquid SuspensionPyrazinamide Related Compound A (Pyrazinecarboxylic acid)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C5H4N2O2Forma y color:White Off-White Crystalline PowderPeso molecular:124.02728Amitriptyline Related Compound B (5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C20H25NOForma y color:White PowderPeso molecular:295.19361Rabeprazole Related Compound B (2-{[(1H-benzo[d]imidazol-2-yl)sulfinyl]methyl}-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFórmula:C18H21N3O4SForma y color:White PowderPeso molecular:375.12528Azithromycin Related Compound F (3'-N-Demethyl-3'-N-formylazithromycin)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C38H70N2O13Forma y color:White PowderPeso molecular:762.48779Fluorescein Related Compound C (2-(2,4-Dihydroxybenzoyl)benzoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFórmula:C14H10O5Forma y color:Off-White Pale Yellow PowderPeso molecular:258.05282Voriconazole Related Compound F ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulfonic acid)
CAS:Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFórmula:C10H16O4SForma y color:White PowderPeso molecular:232.07693p-Ranolazine (N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]piperazin-1-yl}acetamide)
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFórmula:C24H33N3O4Forma y color:White PowderPeso molecular:427.24711Cetirizine Related Compound A ((RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester oxalate)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C25H31ClN2O7Forma y color:White PowderPeso molecular:506.98Amoxicillin Related Compound G ((2S,5R,6R)-6-{(R)-2-[(R)-2-Amino-2-(4-hydroxyphenyl)acetamido]-2-(4-hydroxyphenyl)acetamido}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C24H26N4O7SForma y color:White PowderPeso molecular:514.15222Valproic Acid Related Compound K (2-Ethyl-2-methylpentanoic acid)
CAS:Saturated acyclic monocarboxylic acids and their anhydrides, halides, peroxides etc, nesoiFórmula:C8H16O2Forma y color:Clear Yellow Oily LiquidPeso molecular:144.11503Glycopyrrolate Related Compound C (2-Cyclopentyl-2-hydroxy-2-phenylacetic acid)
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFórmula:C13H16O3Forma y color:White Off-White PowderPeso molecular:220.10994Bis(2-ethylhexyl)maleate (Maleic acid, bis(2-ethylhexyl)ester)
CAS:Maleic acid not in us note 3 section 6Fórmula:C20H36O4Forma y color:LiquidPeso molecular:340.51Zidovudine Related Compound D ([1-(2-Deoxy-β-D-ribofuranosyl)]thymine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C10H14N2O5Forma y color:White Crystalline PowderPeso molecular:242.09027Latanoprost Related Compound A (Isopropyl (E)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoate)
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFórmula:C26H40O5Forma y color:White Off-White PowderPeso molecular:432.28757Methotrexate Related Compound C ((S)-2-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl](methyl)amino}benzamido) pentanedioic acid)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C20H21N7O6Forma y color:Dark Yellow Orange PowderPeso molecular:455.15533Rabeprazole Related Compound C (1H-Benzimidazole-2-thiol)
CAS:Aromatic or modified aromatic heterocyclic compounds wiFórmula:C7H6N2SForma y color:White Light Yellow PowderPeso molecular:150.02517Quetiapine Related Compound B (11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C17H17N3S·2HClForma y color:Off-White PowderPeso molecular:295.11432Moxifloxacin Related Compound G (1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, monohydrochloride)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFórmula:C21H24FN3O4·HClForma y color:Yellow PowderPeso molecular:437.15176Lamotrigine Related Compound C (3-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5(4H)-one)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFórmula:C9H6Cl2N4OForma y color:White Off-White PowderPeso molecular:255.99187Clobetasol Propionate Related Compound A (9α-Fluoro-11β-hydroxy-16β-methyl 3-oxo-androsta-1,4-diene-17(R)-spiro-2'-[4'-chloro-5'-ethylfuran-3'(2'H)-one])
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFórmula:C25H30ClFO4Forma y color:White PowderPeso molecular:448.18167Gatifloxacin Related Compound E (1-Cyclopropyl-6-fluoro-8-methoxy-7-(2-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monohydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C19H22FN3O4·HClForma y color:SolidPeso molecular:411.13611Terbinafine Related Compound B ((2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine hydrochloride)
CAS:Aromatic monoamines not elsewhere specified or includedFórmula:C21H25N·HClForma y color:Off-White PowderPeso molecular:291.1987Flavoxate Related Compound C (Ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C19H16O4Forma y color:White Off-White PowderPeso molecular:308.10486Desogestrel Related Compound A (13-Ethyl-11-methylene-18,19-dinor-5α,17α-pregn-3-en-20-yn-17-ol)
CAS:Sterols and inositolsFórmula:C22H30OForma y color:White PowderPeso molecular:310.22967Valproic Acid Related Compound A (2-allylpent-4-enoic acid)
CAS:Unsaturated acyclic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives, nesoiFórmula:C8H12O2Forma y color:Clear LiquidPeso molecular:140.08373Ticagrelor R,S-Cyclopropyl Isomer
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C23H28F2N6O4SForma y color:White Off-White SolidPeso molecular:522.18608Theophylline Related Compound C (N-(6-Amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C7H10N4O3Forma y color:Off-White PowderPeso molecular:198.07529Acyclovir Related Compound G (2-{[2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy}ethyl acetate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C12H15N5O5Forma y color:White Pale Yellow PowderPeso molecular:309.10732Febuxostat Related Compound C (Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C14H12N2O3SForma y color:Off-White Fine PowderPeso molecular:288.05686Rufinamide Related Compound B (Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate)
CAS:Aromatic or modified aromatic heterocyclic compounds wiFórmula:C11H9F2N3O2Forma y color:White PowderPeso molecular:253.06628Zolmitriptan Related Compound H (4,4-Diethoxy-N,N-dimethylbutan-1-amine)
CAS:Non-aromatic amino-compounds with oxygen functionFórmula:C10H23NO2Forma y color:Clear Colorless LiquidPeso molecular:189.17288Tranexamic Acid Related Compound C ((RS)-4-(Aminomethyl)cyclohex-1-enecarboxylic acid hydrochloride)
CAS:Amino-acids and their esters other than those containing more than one kind of oxygen function, excluding aromatic amino-acids, nesoiFórmula:C8H13NO2·HClForma y color:White Off-White PowderPeso molecular:191.07131Tizanidine Related Compound B (N-acetyltizanidine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C11H10ClN5OSForma y color:Yellow PowderPeso molecular:295.02946Granisetron Related Compound A (2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C18H24N4OForma y color:White Off-White PowderPeso molecular:312.19501Gabapentin Related Compound B ((1-cyanocyclohexyl)acetic acid)
CAS:Nitrile function compounds, nesoiFórmula:C9H13NO2Forma y color:PowderPeso molecular:167.09463Oxazepam Related Compound A (7-Chloro-5-phenyl-4,5-dihydro-1H-benzodiazepine-2,3-dione)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C15H11ClN2O2Forma y color:White Off-White PowderPeso molecular:286.05091Bisoprolol Related Compound A (1-[4-(Hydroxymethyl)phenoxy]-3-(isopropylamino)propan-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C13H21NO3Forma y color:Beige SolidPeso molecular:239.15214Clopidogrel Open Ring Methyl Ester Hydrochloride (methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H16ClNO2SHClForma y color:White Off-White SolidPeso molecular:346.28Prednicarbate Related Compound C (prednisolone-21-propionate)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C24H3206Forma y color:PowderPeso molecular:3519.08705Gadodiamide Related Compound A (Gadolinium sodium diethylenetriamine pentaacetic acid monomethylamide)
CAS:Compounds, inorganic or organic, of rare-earth metals, of yttrium or of scandium, or of mixtures of these metals, nesoi (excluding cerium compounds)Fórmula:C15H22GdN4NaO9Forma y color:White Off-White Pale Yellow PowderPeso molecular:583.05256Betamethasone Dipropionate Related Compound F (9,11β-Epoxy-16β-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFórmula:C28H36O7Forma y color:White Off-White PowderPeso molecular:484.2461Spironolactone Related Compound I (S-[17α-(Ethoxymethyl)-17-hydroxy-3-oxoandrost-4-en-7α-yl]ethanethioate)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C24H36O4SForma y color:White PowderPeso molecular:420.23343Metaxalone Related Compound C (Bis[2-hydroxy-3-(3,5-dimethylphenoxy)propyl]amine)
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFórmula:C22H31NO4Forma y color:White PowderPeso molecular:373.22531Cefepime Related Compound D ((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C6H7N3O3SForma y color:Off-White Light Brown PowderPeso molecular:201.02081N-Nitroso Dabigatran Etexilate Solution (1 mL ) (ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C34H40N8O6Forma y color:Colorless LiquidPeso molecular:656.30708Piroxicam Related Compound B (4-Hydroxy-N-(pyridin-2-yl)-2H-benzothiazine-3-carboxamide 1,1-dioxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H11N3O4SForma y color:Green Yellow PowderPeso molecular:317.04703Acetaminophen Related Compound J (N-(4-chlorophenyl)acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C8H8ClNOForma y color:White Light Yellow Brown Crystalline PowderPeso molecular:169.61 g/molRoflumilast Related Compound D (3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFórmula:C12H12F2O4Forma y color:Yellow White PowderPeso molecular:258.07037Theophylline Related Compound B (3-Methyl-1H-purine-2,6-dione)
CAS:Theophylline and aminophylline (excluding fenetylline) and their derivatives, salts thereof, not elsewhere specified or includedFórmula:C6H6N4O2Forma y color:Light Yellow PowderPeso molecular:166.04908Benazepril Related Compound F (tert-Butyl-3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid)
CAS:<p>Lactams not elsewhere specified or included</p>Fórmula:C16H22N2O3Forma y color:White Off-White Crystalline PowderPeso molecular:290.16304Bimatoprost
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFórmula:C25H37NO4Forma y color:White Off-White PowderPeso molecular:415.27226Febuxostat
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C16H16N2O3SForma y color:White Off-White PowderPeso molecular:316.08816Azithromycin Related Compound H (3'-N-{[4-(Acetylamino)phenyl]sulfonyl}-3'-N-demethylazithromycin)
CAS:Sulfonamides, nesoiFórmula:C45H77N3O15SForma y color:White PowderPeso molecular:931.50754Bisacodyl Related Compound C (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C20H17NO3Forma y color:SolidPeso molecular:319.12084Felbamate Related Compound A (3-Hydroxy-2-phenylpropyl carbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C10H13NO3Forma y color:White Crystalline PowderPeso molecular:195.08954Zonisamide Related Compound C (N'-(benzisoxazol-3-ylmethylsulfonyl)-N,N-dimethylformimidamide)
CAS:Sulfonamides, nesoiFórmula:C11H13N3O3SForma y color:White SolidPeso molecular:267.06776Doxazosin Related Compound A (N-1,4-Benzodioxane-2-carbonyl piperazine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C13H16N2O3·HClForma y color:White PowderPeso molecular:248.11609Indapamide Related Compound A (4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide)
CAS:Sulfonamides, nesoiFórmula:C16H14ClN3O3SForma y color:Yellow Brown PowderPeso molecular:363.04444Desthiophenerivaroxaban Phthalimodo Analog ((R)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C22H19N3O6Forma y color:White Off-White SolidPeso molecular:421.12739Pramipexole Related Compound D ((R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride)
CAS:Compounds containing a benzothiazole ring-system (whethFórmula:C10H17N3S·2HClForma y color:Off-White PowderPeso molecular:283.06767Fluorouracil Related Compound E (5-Chloropyrimidine-2,4(1H,3H)-dione)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C4H3ClN2O2Forma y color:White Off-White PowderPeso molecular:145.98831Ranitidine Related Compound C (N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-1,1-ethenediamine)
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFórmula:C13H22N4O4SForma y color:Off-White SolidPeso molecular:330.13618Cromolyn Related Compound B (Diethyl 5,5'-[(2-hydroxypropane-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromene-2-carboxylate))
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C27H24O11Forma y color:Cream Light Brown PowderPeso molecular:524.13186Benazepril Related Compound B (2-[(S)-3-{[(R)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl]acetic acid hydrochloride)
CAS:Lactams not elsewhere specified or includedFórmula:C24H28N2O5·HClForma y color:White Fluffy PowderPeso molecular:424.19982Doxazosin Related Compound F (N,N'-bis(1,4-benzodioxane-2-carbonyl)piperazine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C22H22N2O6Forma y color:White Off-White PowderPeso molecular:410.14779Diphenhydramine Related Compound B (3-(benzhydryloxy)propane-1,2-diol)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFórmula:C16H18O3Forma y color:SolidPeso molecular:258.12559Linezolid R-Isomer (N-{[(R)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl}acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H20FN3O4Forma y color:White Off-White Solid PowderPeso molecular:337.14378Desoximetasone Related Compound A (9-Fluoro-11β,21-dihydroxy-16α-methylpregna-4-ene-3,20-dione)
CAS:Halogenated derivatives of adrenal cortical hormonesFórmula:C22H31FO4Forma y color:Off-White Beige SolidPeso molecular:378.22064Lorazepam Related Compound D (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C15H8Cl2N2O2Forma y color:White PowderPeso molecular:317.99628Ibuprofen Related Compound C (4-isobutylacetophenone)
CAS:Aromatic ketones without other oxygen function, nesoiFórmula:C12H16OForma y color:Clear Colourless To Light Yellow LiquidPeso molecular:176.12012Clopidogrel N-Oxide (5-((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H16ClNO3SForma y color:Pale Yellow SolidPeso molecular:337.05394Zoledronic Acid Related Compound A (2-(1H-Imidazol-1-yl)acetic acid)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C5H6N2O2Forma y color:White PowderPeso molecular:126.042932-Oxo R-Clopidogrel (methyl (2R)-2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H16ClNO3SForma y color:White Off-White SolidPeso molecular:337.05394Tranylcypromine Related Compound B ((E)-3-Phenylallylamine hydrochloride)
CAS:Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFórmula:C9H11N·HClForma y color:White PowderPeso molecular:133.08915Nicotine Related Compound F (3-(pyrrolidin-2-yl)pyridine)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C9H12N2Forma y color:Colorless Translucent Oily LiquidPeso molecular:148.10005N-Benzyl-N-methyl-ethanolamine (2-[benzyl(methyl)amino]ethanol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C10H15NOForma y color:Clear Yellow LiquidPeso molecular:165.11536Chloroquine Related Compound D (7-Chloro-4-{[4-(ethylamino)-1-methylbutyl] amino} quinoline)
CAS:Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFórmula:C16H22ClN3Forma y color:Tan PowderPeso molecular:291.150236-Ketonorethindrone Acetate (3,6-Dioxo-19-nor-17α pregn-4-en-20-yn-17-yl acetate)
CAS:Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFórmula:C22H26O4Forma y color:Light Yellow PowderPeso molecular:354.183112-Amino-5-chlorobenzophenone
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFórmula:C13H10ClNOForma y color:Yellow Crystalline PowderPeso molecular:231.04509Iopamidol Related Compound A (N,N'-Bis-(1,3-dihydroxy-2-propyl)-5-amino-2,4,6-triiodoisophthalamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C14H18I3N3O6Forma y color:White PowderPeso molecular:704.83298Dronedarone Related Compound A (N-{2-Butyl-3-[4-(3-butylaminopropoxy)benzoyl]benzofuran-5-yl}methanesulfonamide, hydrochloride)
CAS:Aromatic pesticides with oxygen heteroFórmula:C27H36N2O5S·HClForma y color:PowderPeso molecular:536.21117Cefprozil (Z)-Isomer
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H19N3O5S·H2OForma y color:PowderPeso molecular:389.10454Clopidogrel Thienopyridinium Chloride (5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)thieno[3,2-c]pyridin-5-ium, chloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H13ClNO2S·ClForma y color:Off-White SolidPeso molecular:318.03555Famciclovir Related Compound B (4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C12H17N5O3Forma y color:Off-White PowderPeso molecular:279.13314Iodixanol Related Compound E (5-{N-[3-(N-{3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C32H38I6N6O13Forma y color:White Off-White PowderPeso molecular:1475.67652Miconazole Related Compound C (2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethan-1-amine hydrochloride)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C15H13Cl4NO·HClForma y color:White Off-White SolidPeso molecular:398.9518Tropicamide Related Compound B (N-ethyl-2-phenyl-N-(pyridin-4-ylmethyl)acrylamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H18N2OForma y color:Brown LiquidPeso molecular:266.14191
amino}benzoic acid, …](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1414058.webp&w=3840&q=75)
![Almotriptan Related Compound A ({3-[2-(Dimethylamino)ethyl]-5-[(pyrrolidine-1-yl)sulfonylmethyl]-1…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1013523.webp&w=3840&q=75)
![Fluvastatin Related Compound B ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1285964.webp&w=3840&q=75)
![Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1370269.webp&w=3840&q=75)
![Buspirone Related Compound L (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1078824.webp&w=3840&q=75)
![Valacyclovir Related Compound E (2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-benzy…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1707872.webp&w=3840&q=75)
![Olanzapine Related Compound B (2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1478323.webp&w=3840&q=75)
![Risperidone Related Compound G (3-{2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-2-methyl-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1604756.webp&w=3840&q=75)
![Orphenadrine Related Compound E (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1479053.webp&w=3840&q=75)
![Voriconazole Related Compound F ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulfo…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1718063.webp&w=3840&q=75)
![Acyclovir Related Compound G (2-{[2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy}ethyl ac…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1012087.webp&w=3840&q=75)
